Up-to-date approach to manage keloids and hypertrophic scars: a useful guide

Burns. 2014 Nov;40(7):1255-66. doi: 10.1016/j.burns.2014.02.011. Epub 2014 Apr 24.

Abstract

Keloids and hypertrophic scars occur anywhere from 30 to 90% of patients, and are characterized by pathologically excessive dermal fibrosis and aberrant wound healing. Both entities have different clinical and histochemical characteristics, and unfortunately still represent a great challenge for clinicians due to lack of efficacious treatments. Current advances in molecular biology and genetics reveal new preventive and therapeutical options which represent a hope to manage this highly prevalent, chronic and disabling problem, with long-term beneficial outcomes and improvement of quality of life. While we wait for these translational clinical products to be marketed, however, it is imperative to know the basics of the currently existing wide array of strategies to deal with excessive scars: from the classical corticotherapy, to the most recent botulinum toxin and lasers. The main aim of this review paper is to offer a useful up-to-date guideline to prevent and treat keloids and hypertrophic scars.

Keywords: Corticoids; Criotherapy; Keloid; Laser; Review; Scar.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Adrenal Cortex Hormones / therapeutic use
  • Aminoquinolines / therapeutic use
  • Anti-Inflammatory Agents / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Bleomycin / therapeutic use
  • Botulinum Toxins, Type A / therapeutic use
  • Cicatrix, Hypertrophic / therapy*
  • Cryotherapy / methods
  • Disease Management
  • Fluorouracil / therapeutic use
  • Humans
  • Imiquimod
  • Injections, Intralesional
  • Interferons / therapeutic use
  • Keloid / therapy*
  • Lasers, Dye / therapeutic use
  • Low-Level Light Therapy / methods
  • Neuromuscular Agents / therapeutic use
  • ortho-Aminobenzoates / therapeutic use

Substances

  • Adjuvants, Immunologic
  • Adrenal Cortex Hormones
  • Aminoquinolines
  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Neuromuscular Agents
  • ortho-Aminobenzoates
  • Bleomycin
  • Interferons
  • Botulinum Toxins, Type A
  • tranilast
  • Imiquimod
  • Fluorouracil